Japanese cedar-PAD (Circassia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameJapanese cedar-PAD (Circassia)
Drug Alias NameJapanese cedar peptide allergy desensitization agent (Circassia)Japanese cedar-SPIREToleroMune Japanese cedar
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNIOX Group Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNIOX Group Plc
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeN/A
Related LinksN/A